Novartis Investigator site
Alzira
0 studies enrolling now · 2 studies all time
What they study most
COPD, Chronic Obstructive Pulmonary Disease
Studies at this site
- Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
- A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed